e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
New models for treating airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung absorption half-life of inhaled drugs can be predicted with rat lung slices
Erica Bäckström (Mölndal, Sweden), Erica Bäckström, Anders Lundqvist, Elin Boger, Margareta Hammarlund-Udenaes, Markus Fridén
Source:
International Congress 2015 – New models for treating airway diseases
Session:
New models for treating airway diseases
Session type:
Poster Discussion
Number:
3571
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Erica Bäckström (Mölndal, Sweden), Erica Bäckström, Anders Lundqvist, Elin Boger, Margareta Hammarlund-Udenaes, Markus Fridén. Lung absorption half-life of inhaled drugs can be predicted with rat lung slices. Eur Respir J 2015; 46: Suppl. 59, 3571
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Tissue distribution of inhalation drugs in rat lung slices
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Prediction of human lung PK for AZD7624, an inhaled P38 inhibitor for the treatment of COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Dobutamine decreases an elevated airway tone similar to dopamine in rats
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway, alveoli, and metastatic tumors in murine lung
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Effect of inhaled liposomal retinoids on the hyperoxia induced lung injury in newborn guinea pigs
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Lung function measurements in mouse models of lung disease: What to expect from FEV0.1?
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Inhalation of chlorine causes lung inflammation and airway hyperresponsiveness in a rat model of chemical-induced lung injury
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Non linear kinetics of absorption of inhaled Benso(a)Pyrene in the isolated perfused and ventilated rat lung
Source: Eur Respir J 2005; 26: Suppl. 49, 151s
Year: 2005
In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Deposition and metabolism of inhaled ciclesonide in the human lung
Source: Eur Respir J 2010; 36: 1113-1119
Year: 2010
Combination study of tiotropium and olodaterol in human precision-cut lung slices
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept